LPL Financial’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.6K Sell
13,916
-76,599
-85% -$85.8K ﹤0.01% 5338
2025
Q1
$71.5K Buy
90,515
+17,395
+24% +$13.7K ﹤0.01% 4972
2024
Q4
$121K Buy
+73,120
New +$121K ﹤0.01% 4832
2021
Q4
Sell
-3,444
Closed -$204K 4360
2021
Q3
$204K Buy
3,444
+609
+21% +$36.1K ﹤0.01% 3942
2021
Q2
$246K Buy
+2,835
New +$246K ﹤0.01% 3735